The Valley Desk

Clinical trial reportJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPublished

Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Acrylamides; Aniline Compounds; Pyrimidines; Indoles; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Mutation; Female; Male
PubMed ID
42061572
Added to directory
Source checked

Report a correction or request removal